Tuesday 13 October 2026 Export all NUS data to Excel Powerpack

Nu Skin Enterprises, Inc.

NUS Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.87 0.13 +2.74%
Market cap
$230.7M
P/E
0.0×
Fwd P/E
5.9×
Dividend yield
4.93%
F-score
7/9
Altman Z
3.78
Beneish M
−2.35
Dividend safety
70/100

Insider Decisions trades per month

Total buys 0.05
Total sells 0.10
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 1 — — — — — — — — — — —
Sell — — — — — — 1 2 — — — —
Insider Ownership 2.79%

Capital & Financial Ratios $m

Market Cap 230.73
Revenue 1,375.25
Net Income (216.39)
Free Cash Flow 10.78
Net Debt 22.28
Current Ratio 1.98 (at or above 1.5: strong)
Debt/Equity 0.39 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E 5.90
P/S ratio 0.17
P/B ratio 0.44
Past 5Y EPS Growth (2.61%) (below 0%: weak)
This Y EPS Growth (35.43%) (below 0%: weak)
Next Y EPS Growth 41.46% (at or above 15%: strong)
Next Y revenue growth (11.32%) (below 0%: weak)
Next 5Y EPS Growth (6.46%) (below 0%: weak)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 2.25%
10-year low 10-year high
P/B against its own 10 years 4.21%
10-year low 10-year high
EV/Sales against its own 10 years 2.21%
10-year low 10-year high
EV/FCF against its own 10 years 82.61%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate 0.24
Annual Dividend Yield 4.93%
total individual payouts
2026 0.24
0.06
0.06
0.06
2025 0.24
0.06
0.06
0.06
0.06
2024 0.24
0.06
0.06
0.06
0.06
2023 1.56
0.39
0.39
0.39
0.39
2022 1.54
0.39
0.39
0.39
0.39
2021 1.52
0.38
0.38
0.38
0.38
2020 1.50
0.38
0.38
0.38
0.38
2019 1.48
0.37
0.37
0.37
0.37
2018 1.46
0.37
0.37
0.37
0.37
2017 1.44
0.36
0.36
0.36
0.36
2016 1.42
0.36
0.36
0.36
0.36
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 268 198 240 191
Receivables 59 51 40 49
Inventory 280 190 179 191
Other 14 27 — —
702 539 548 508
2023 2024 2025 Q'26
Payables 43 35 26 38
ST’ Debt 25 30 20 20
Other 7 14 — —
329 297 264 256

Compound Annual Growth %

10y 5y 3y
Sales (4.06%) (10.47%) (12.61%)
Cash Flow (12.97%) (26.69%) (9.43%)
Earnings 1.87% (3.49%) 15.20%
Book Value (0.25%) (2.08%) (3.54%)

Revenue $m

Mar Jun Sep Dec Year
’26 321 320 — — —
’25 364 386 364 370 1,485
’24 417 439 430 446 1,732
’23 481 500 499 489 1,969
’22 605 561 538 522 2,226
’21 677 704 641 673 2,696
’20 518 612 703 748 2,582
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (4) 11 — — —
’25 0 36 27 17 80
’24 3 51 31 26 112
’23 (22) 36 51 54 119
’22 8 47 28 26 108
’21 (19) 21 30 110 142
’20 69 97 118 95 379
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (18) 5 — — —
’25 (13) 36 18 6 46
’24 (9) 43 23 13 70
’23 (34) 21 39 34 60
’22 (3) 37 3 12 49
’21 (38) 3 17 91 73
’20 50 88 98 80 315
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.04 (5.14) — — —
’25 2.14 0.43 0.34 0.29 3.18
’24 (0.01) (2.38) 0.17 (0.73) (2.95)
’23 0.23 0.54 (0.74) 0.15 0.17
’22 0.76 0.67 (0.51) 1.15 2.07
’21 0.91 1.15 0.97 (0.18) 2.86
’20 0.36 0.81 1.08 1.40 3.63
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 23.51 47.10 56.09 35.03 12.31 39.40 29.96 16.15 5.95 5.32

Analyst estimates 2026–2028

Powerpack
High 66.04 70.27 88.68 69.79 57.01 63.85 56.76 45.55 20.75 14.62
People
People Employees 4,650 4,700 4,900 4,900 5,000 4,600 3,800 3,700 3,100 2,800
Revenue/emp, $m 0.47 0.48 0.55 0.49 0.52 0.59 0.59 0.53 0.56 0.53
Income, $m
Income, $m Revenue 2,208 2,279 2,679 2,420 2,582 2,696 2,226 1,969 1,732 1,485
Gross margin, % 77.33 77.97 76.33 75.98 74.51 74.95 71.65 68.93 68.23 69.45
EBT 213 266 220 255 256 232 89 27 (175) 196
EBT margin, % 9.64 11.65 8.20 10.54 9.92 8.62 4.00 1.35 (10.11) 13.21
Net income 143 129 122 174 191 147 105 9 (147) 160
Depreciation 72 72 83 77 74 76 73 71 70 52
Per share, $
Per share, $ Revenue 39.84 43.16 48.56 43.60 49.37 53.71 44.51 39.61 34.88 30.13
Earnings 2.58 2.45 2.21 3.13 3.66 2.93 2.10 0.17 (2.95) 3.25
Cash flow 4.97 5.73 3.67 3.20 7.25 2.82 2.16 2.39 2.25 1.63
Capex (0.91) (1.14) (1.28) (1.19) (1.22) (1.37) (1.18) (1.18) (0.84) (0.70)
Free cash flow 4.06 4.59 2.40 2.01 6.03 1.45 0.98 1.21 1.41 0.93
Book value 11.98 13.34 14.17 15.77 17.10 18.19 17.95 16.53 13.12 16.34
Shares, m 55 53 55 56 52 50 50 50 50 49
Valuation, ×
Valuation, × P/E 18.83 27.98 27.63 13.13 14.73 17.38 20.12 112.89 0.00 2.97
P/S 1.22 1.59 1.26 0.94 1.11 0.95 0.95 0.51 0.20 0.32
P/B 4.07 5.14 4.33 2.60 3.19 2.79 2.35 1.23 0.53 0.59
EV/Sales 1.25 1.57 1.28 0.95 1.07 0.95 1.00 0.63 0.31 0.31
EV/FCF 12.23 14.73 25.81 20.50 8.78 35.20 45.64 20.70 7.67 9.97
Cash, $m
Cash, $m Operating cash flow 275 303 203 178 379 142 108 119 112 80
Capex (50) (60) (70) (66) (64) (69) (59) (58) (42) (34)
Free cash flow 225 242 132 112 315 73 49 60 70 46
Balance, $m
Balance, $m Working capital 315 330 360 383 360 343 401 373 242 284
Total debt 417 389 430 362 335 376 402 503 394 224
Net debt 49 (50) 32 18 (89) 21 124 235 196 (16)
Shareholders’ equity 664 705 782 875 894 913 897 822 651 805
Returns, %
Returns, % ROA 9.60 8.45 7.42 10.02 10.27 7.62 5.62 0.47 (8.95) 11.15
ROIC 20.26 26.19 18.49 18.71 19.98 15.65 6.78 2.85 (11.18) 5.21
ROE 19.21 18.91 16.40 20.95 21.63 16.30 11.58 1.00 (19.90) 22.00
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Nu Skin Enterprises, Inc. vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
HELE Helen of Troy Limited $620.1M — (loss-making) 9.3× +2.12% (above 0%: growing) n/m −114.24% (below 0%: shrinking) 52.19% 5.20% Compare
HNST The Honest Company, Inc. $543.9M — (loss-making) 105× −10.87% (below 0%: shrinking) +233.33% (above 0%: growing) +3,911.74% (above 0%: growing) 48.45% 11.50% Compare
MAGN Magnera Corporation $411.7M — (loss-making) — (loss-making) +2.15% (above 0%: growing) n/m −115.38% (below 0%: shrinking) 13.07% 2.57% Compare
ACU Acme United Corporation. $238.3M 24.2× 31.0× +16.15% (above 0%: growing) +4.76% (above 0%: growing) +155.61% (above 0%: growing) 42.55% 10.89% Compare
NUS Nu Skin Enterprises, Inc. $230.7M — (loss-making) 5.9× −17.10% (below 0%: shrinking) n/m −86.06% (below 0%: shrinking) 68.20% (18.53%)
YSG Yatsen Holding Limited Sponsored ADR $164.5M — (loss-making) 32.2× +10.97% (above 0%: growing) n/m +14.56% (above 0%: growing) 73.88% (11.55%) Compare
MLKMF Waldencast PLC $111.9M — (loss-making) — (loss-making) — n/m −345.38% (below 0%: shrinking) 46.91% 0.00% Compare
SLSN Solesence, Inc. $72.1M — (loss-making) — −24.69% (below 0%: shrinking) n/m +86.52% (above 0%: growing) 30.97% 0.79% Compare
SKIN SkinHealth Systems Inc. $71.6M — (loss-making) — (loss-making) −7.77% (below 0%: shrinking) n/m −81.89% (below 0%: shrinking) 68.42% 4.95% Compare
Median of peers $201.4M — 31.6× +2.12% — −33.66% 47.68% 3.76%

All 32 Household & Personal Products stocks →

Nu Skin Enterprises, Inc. (NUS) key facts

  • Concern: Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024.
  • Nu Skin Enterprises, Inc. (NUS) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
  • Net income was $160.2 million, or $3.25 per share (basic), a net margin of 10.8%.
  • As of October 12, 2026, NUS traded at $4.87, a market capitalization of $230.7 million.
  • Nu Skin Enterprises, Inc. pays an annual dividend of $0.24 per share, a yield of 4.93%.
  • Return on equity was 22.0% and debt-to-equity 0.39.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.78 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Nu Skin Enterprises, Inc. (NUS) Latest News

11 Aug

Impact 3 · transcript
stockrow.com/NUS · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com